1. Home
  2. AQST vs HYLN Comparison

AQST vs HYLN Comparison

Compare AQST & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

SELL

Current Price

$3.76

Market Cap

529.4M

Sector

Health Care

ML Signal

SELL

Logo Hyliion Holdings Corp.

HYLN

Hyliion Holdings Corp.

SELL

Current Price

$2.20

Market Cap

534.0M

ML Signal

SELL

Company Overview

Basic Information
Metric
AQST
HYLN
Founded
2004
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
529.4M
534.0M
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
AQST
HYLN
Price
$3.76
$2.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
★ $9.33
$7.75
AVG Volume (30 Days)
★ 2.4M
1.6M
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $67,430,000.00
$3,475,000.00
Revenue This Year
$11.13
$423.05
Revenue Next Year
$40.69
$101.85
P/E Ratio
N/A
★ N/A
Revenue Growth
0.77
★ 130.28
52 Week Low
$2.94
$1.56
52 Week High
$6.74
$8.49

Technical Indicators

Market Signals
Indicator
AQST
HYLN
Relative Strength Index (RSI) 43.59 30.25
Support Level $3.59 $1.78
Resistance Level $4.34 $4.62
Average True Range (ATR) 0.25 0.30
MACD 0.02 -0.06
Stochastic Oscillator 41.85 2.18

Price Performance

Historical Comparison
AQST
HYLN

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About HYLN Hyliion Holdings Corp.

Hyliion Holdings Corp designs and develops power generators for stationary and mobile applications and provides R&D service. It provides solutions that enable clean, flexible, and affordable electricity production. The company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies. Its products and services include: KARNO Power Modules which is a modular, fully enclosed, fuel-agnostic and fully integrated power generating solution.

Share on Social Networks: